Pharma Journalist 8786 posts 0 comments

Immunomedics announced a clinical collaboration with AstraZeneca and its global biologics research and development arm, MedImmune, to evaluate the safety and efficacy of the combination…
Read More...

Adamis Pharmaceuticals Corporation announced that it has been conducting pre-IND development work for a fast-dissolving sublingual tablet containing tadalafil. Adamis intends to submit…
Read More...

Cambrex Corporation announced it has entered into a definitive agreement to acquire Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO),…
Read More...

Koutif Therapeutics announced that KT-1002, which has been selected as its lead compound, has reached clinical candidate status for the treatment of inflammatory bowel disease,…
Read More...

Medical Fair China 2018 (MFC) will be held on 6-8 September, 2018 in Suzhou together with the grand launch of the Global Device Week. MFC will be covering a total area of 15,000 square…
Read More...

Kite, a Gilead Company and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors (TCRs),…
Read More...

MorphoSys AG and Galapagos NV announced that they have entered into a worldwide, exclusive agreement with Novartis Pharma AG covering the development and commercialization of their…
Read More...

The Hong Kong Polytechnic University (PolyU) will join forces with Axis Therapeutics, a newly established joint venture by two global biopharmaceutical companies - Athenex, Inc. and…
Read More...

About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The invariably fatal disease kills the nerve cells that…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved SYMTUZA, the first and only complete,…
Read More...